
Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis
Keywords: آیتم های گزارش مورد نظر برای بررسی های سیستماتیک و متا آنالیز; CCA; cholangiocarcinoma; FISH; fluorescence in situ hybridization; ICER; incremental cost-effectiveness ratio; PSC; primary sclerosing cholangitis; PRISMA; Preferred Reporting Items for Systematic Reviews and Meta-Analyses; QALY; quality-adjusted life yea